Literature DB >> 3520322

Group B streptococcal infection in newborns: prevention at last?

C J Baker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3520322     DOI： 10.1056/NEJM198606263142609

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Immunoglobulin therapy for neonatal sepsis: an overview of animal and clinical studies.

Authors:  G W Fischer
Journal:  J Clin Immunol       Date:  1990-11       Impact factor: 8.317

2.  Interleukin-10 protects neonatal mice from lethal group B streptococcal infection.

Authors:  V Cusumano; F Genovese; G Mancuso; M Carbone; M T Fera; G Teti
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Group B streptococcal opacity variants.

Authors:  S H Pincus; R L Cole; M R Wessels; M D Corwin; E Kamanga-Sollo; S F Hayes; W Cieplak; J Swanson
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

5.  Interaction of group B streptococcal opacity variants with the host defense system.

Authors:  S H Pincus; R L Cole; E Kamanga-Sollo; S H Fischer
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

6.  Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci.

Authors:  G Mancuso; V Cusumano; F Genovese; M Gambuzza; C Beninati; G Teti
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Role of gamma interferon in a neonatal mouse model of group B streptococcal disease.

Authors:  V Cusumano; G Mancuso; F Genovese; D Delfino; C Beninati; E Losi; G Teti
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

8.  Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates.

Authors:  Vitaliano Cusumano; Angelina Midiri; Valentina Valeria Cusumano; Antonella Bellantoni; Giuseppe De Sossi; Giuseppe Teti; Concetta Beninati; Giuseppe Mancuso
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Phenotypic diversity in the alpha C protein of group B streptococci.

Authors:  L C Madoff; S Hori; J L Michel; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.